Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patients

BACKGROUND: Febuxostat is a novel xanthine oxidase inhibitor. However, few studies have examined the long-term efficacy and tolerability of febuxostat after switching from allopurinol in hemodialysis (HD) patients. Therefore, the present study evaluated the long-term efficacy and tolerability of feb...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitsuboshi, Satoru, Yamada, Hitoshi, Nagai, Kazuhiko, Okajima, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729117/
https://www.ncbi.nlm.nih.gov/pubmed/26819739
http://dx.doi.org/10.1186/s40780-015-0028-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729117/
https://www.ncbi.nlm.nih.gov/pubmed/26819739
http://dx.doi.org/10.1186/s40780-015-0028-1

Ejemplares similares